Bicara Therapeutics Inc. ... (BCAX)
Bicara Therapeutics Common Stock Max Pain By Strike
BCAX trades at $17.04, 36.3% above the near-term max pain of $12.5 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is stable across expirations ($10-$15), indicating stable market expectations. Key magnetic zone at 13 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Bicara Therapeutics Common Stock Max Pain By Expiry
Max pain for BCAX shows stable levels around 12.50, reflecting balanced market expectations. The 40% spread signals divergent expectations across timeframes. Most levels below 17.04 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Oct 17, 2025 | 12.5 | n/a (n/a) |
| Nov 21, 2025 | 15 | n/a (n/a) |
| Jan 16, 2026 | 10 | n/a (n/a) |
| Apr 17, 2026 | 12.5 | n/a (n/a) |